Cited by 54Amyotrophic Lateral Sclerosis ResearchNeuroscience and Neuropharmacology ResearchAlzheimer's disease research and treatments

Altered network properties in C9ORF72 repeat expansion cortical neurons are due to synaptic dysfunction

Open access
Perkins, Emma M., Burr, Karen, Banerjee, Poulomi, Mehta, Arpan R., Dando, Owen, Selvaraj, Bhuvaneish T., Suminaite, Daumante, Nanda, Jyoti +6 more·2021·Molecular Neurodegeneration

Abstract

Background: Physiological disturbances in cortical network excitability and plasticity are established and widespread in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) patients, including those harbouring the C9ORF72 repeat expansion (C9ORF72RE) mutation – the most common genetic impairment causal to ALS and FTD. Noting that perturbations in cortical function are evidenced pre-symptomatically, and that the cortex is associated with widespread pathology, cortical dysfunction is thought to be an early driver of neurodegenerative disease progression. However, our understanding of how altered network function manifests at the cellular and molecular level is not clear. Methods: To address this we have generated cortical neurons from patient-derived iPSCs harbouring C9ORF72RE mutations, as well as from their isogenic expansion-corrected controls. We have established a model of network activity in these neurons using multi-electrode array electrophysiology. We have then mechanistically examined the physiological processes underpinning network dysfunction using a combination of patch-clamp electrophysiology, immunocytochemistry, pharmacology and transcriptomic profiling. Results: We find that C9ORF72RE causes elevated network burst activity, associated with enhanced synaptic input, yet lower burst duration, attributable to impaired pre-synaptic vesicle dynamics. We also show that the C9ORF72RE is associated with impaired synaptic plasticity. Moreover, RNA-seq analysis revealed dysregulated molecular pathways impacting on synaptic function. All molecular, cellular and network deficits are rescued by CRISPR/Cas9 correction of C9ORF72RE. Our study provides a mechanistic view of the early dysregulated processes that underpin cortical network dysfunction in ALS-FTD. Conclusion: These findings suggest synaptic pathophysiology is widespread in ALS-FTD and has an early and fundamental role in driving altered network function that is thought to contribute to neurodegenerative processes in these patients. The overall importance is the identification of previously unidentified defects in pre and postsynaptic compartments affecting synaptic plasticity, synaptic vesicle stores, and network propagation, which directly impact upon cortical function.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s13024-021-00433-8

Cites

66 of 66 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Perkins, E. M., Burr, K., Banerjee, P., Mehta, A. R., Dando, O., Selvaraj, B. T., Suminaite, D., Nanda, J., Henstridge, C. M., Gillingwater, T. H., Hardingham, G. E., Wyllie, D. J. A., Chandran, S., & Livesey, M. R.
Affiliations
  • Euan MacDonald Centre for Motor Neuron Disease Research (GB)
  • UK Dementia Research Institute (GB)
  • University of Dundee (GB)
  • Institute for Stem Cell Biology and Regenerative Medicine (IN)
  • Simons Initiative for the Developing Brain (GB)
Corresponding author
  • Chandran, Siddharthan
  • Livesey, Matthew R.
Venue
Molecular Neurodegeneration
Published
2021-03-04
Volume
16
Issue
1
Pages
13-13
ISSN
1750-1326 (ISSN-L)
OpenAlex
W3135140647
Cited by
54
References
66
Citations by year
2026: 11 · 2025: 5 · 2024: 8 · 2023: 11 · 2022: 14 · 2021: 5
FWCI
4.54
Type
journal article
Language
en
Open access
Locations
  • Molecular Neurodegeneration (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Discovery Research Portal (University of Dundee) (publishedVersion, cc-by)
  • White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
  • Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Wellcome Trust (092742/Z/10/Z, 092742)
  • MND Scotland
  • Alzheimer's Society
  • International Seafood Sustainability Foundation
  • Motor Neurone Disease Association (MEHTA/JUL17/948-795, MR/R001162/1)
  • Rosetrees Trust (Seedcorn2020 100144)
  • University of Edinburgh
  • Department of Biotechnology, Ministry of Science and Technology, India
  • UK Dementia Research Institute
  • Medical Research Council (MR/L023784/2, MR/R001162/1)
Topics
  • Health Sciences › Medicine › Neurology › Amyotrophic Lateral Sclerosis Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
Keywords
C9orf72 repeat expansion, amyotrophic lateral sclerosis, frontotemporal dementia, synaptic dysfunction, synaptic plasticity, iPSC-derived cortical neurons, CRISPR/Cas9 gene correction, RNA-seq, neurodegeneration
MeSH terms
C9orf72 Protein, Amyotrophic Lateral Sclerosis, Humans, Motor Neurons, Mutation, Neurodegenerative Diseases, DNA Repeat Expansion, Induced Pluripotent Stem Cells, Frontotemporal Dementia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review